Comorbidity - Articles | CARLAT PUBLISHING

CARLAT WEBINAR

How to Treat Depression in Older Adults

July 8, 2024

0.50 CME Credits. Learn how to address depression in older adults, identify the risk factors and triggers, distinguish depression from normal aging, and explore effective treatment options.

Clinical Update

The Antipsychotic-Stimulant Combo

September 1, 2023

Avneet Soin, MD., Chris Aiken, MD, and Deepti Anbarasan, MD.

Avneet Soin, MD. Psychiatry resident, NYU Grossman School of Medicine. Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.

Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York

Dr. Soin, Dr. Anbarasan, and Dr. Aiken have no financial relationships with companies related to this material.

As antipsychotic indications have spread, more patients are taking them in combination with their opposite: a stimulant. We look at the risks, search for scenarios where it might make sense, and come up with an action plan for this paradoxical pairing.

Expert Q&A

Addressing Suicidality in Autistic Children and Teens

April 1, 2023

Paul Lipkin, MD

Paul Lipkin, MD.

Neurodevelopmental and developmental behavioral pediatrician. Director, Medical Outpatient Services, Kennedy Krieger Institute, Baltimore, MD.

Dr. Lipkin has served as an advisor for EarliTec and Sarepta Diagnostics. Relevant financial relationships listed for the author have been mitigated.

Autistic kids and teens can become despondent or suicidal. When this happens, we need to take it as seriously as with anyone else. We interviewed Dr. Paul Lipkin who has truly useful tips to help us modify our assessment to communicate effectively back and forth to address the problem.

Expert Q&A

Recognizing and Treating Substance-Induced Psychosis

April 1, 2023

David Beckmann, MD, MPH

David Beckmann, MD, MPH.

Assistant professor of psychiatry and human behavior, Sidney Kimmel Medical College, Thomas Jefferson University. Philadelphia, PA.

Dr. Beckmann has no financial relationships with companies related to this material.

Clinical pearls on how to assess and treat substance-induced psychosis when you come across them in your clinic.

EXPERT Q&A

Managing Alcohol Withdrawal in the Emergency Department

January 30, 2023

Brian Fuehrlein, MD, PhD

Brian Fuehrlein, MD, PhD.

Addiction psychiatrist. Associate professor of psychiatry, Yale University. Director of the psychiatric emergency department at VA Connecticut. West Haven, CT.

Dr. Fuehrlein has no financial relationships with companies related to this material.

Alcohol withdrawal is among the most commonly encountered scenarios managed by psychiatrists in the ED. Here, Dr. Fuehrlein discusses the natural history of alcohol withdrawal, how best to assess withdrawal risk, and choose between treatment options.

CLINICAL UPDATE

Trauma and Addiction

October 31, 2022

Will Rutland MD, JD, MPH

Will Rutland, MD, JD, MPH. Assistant Professor and Psychiatry Clerkship Director, UAB Heersink, School of Medicine, Montgomery Regional Campus. Montgomery, AL.

Dr. Rutland, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Here, we describe treatment approaches for patients with comorbid addiction and PTSD.

CLINICAL UPDATE

Trichotillomania: Diagnosis and Treatment

October 30, 2022

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA. Dr. Posternak has no financial relationships with companies related to this material.

Trichotillomania (TTM) is a disorder that seems to lurk in the shadows. We hear about it but rarely see it.

What Gets in the Way of Antidepressants?

August 1, 2022

Chris Aiken, MD and Garrett Rossi, MD.

Garrett Rossi, MD.
Inpatient/consult attending psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Chris Aiken, MD.
Editor-in-Chief, The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.

Dr. Rossi and Dr. Aiken, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Recent research has added to our understanding of factors that inhibit response to treatment, including major stress, nonadherence, and anxiety.

Addiction and Borderline Personality Disorder

July 1, 2022

Ashley Pierson, PhD

Ashley Pierson, PhD

Assistant Professor of Psychiatry and acting director of DBT services, General Adult Intensive Outpatient Program, Yale University, New Haven, CT.

Dr. Pierson, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Borderline personality disorder is highly comorbid with substance use disorders for reasons that are described by Dr. Pierson. She also reviews some basics of dialectical behavioral therapy, the gold standard treatment for borderline personality disorder, and shows us how therapeutic principles can be applied the treatment of addiction.

RESEARCH UPDATE

Should Prolonged Abstinence From Alcohol Be Required Before Liver Transplant?

July 1, 2022

Deepti Anbarasan, MD. and Sonya Bakshi, MD

Sonya Bakshi, MD, and Deepti Anbarasan, MD.

Dr. Bakshi and Dr. Anbarasan, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Patients with alcohol-associated liver disease have traditionally needed to demonstrate an ability to refrain from drinking for 6 months before being deemed eligible for a liver transplant, despite the absence of research findings to support this requirement. Findings from this retrospective study show that a waiting period is not associated with improved outcomes.